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Programmed cell death during neuronal development:
the sympathetic neuron model
M Kristiansen1 and J Ham*,1
Developing sympathetic neurons of the superior cervical ganglion are one of the best studied models of neuronal apoptosis.
These cells require nerve growth factor (NGF) for survival at the time that they innervate their final target tissues during late
embryonic and early postnatal development. In the absence of NGF, developing sympathetic neurons die by apoptosis in a
transcription-dependent manner. Molecular studies of sympathetic neuron apoptosis began in the 1980s. We now know that NGF
withdrawal activates the mitochondrial (intrinsic) pathway of apoptosis in sympathetic neurons cultured in vitro, and the roles of
caspases, Bcl-2 (B-cell CLL/lymphoma 2) family proteins and XIAP (X-linked inhibitor of apoptosis protein) have been extensively
studied. Importantly, a considerable amount has also been learned about the intracellular signalling pathways and transcription
factors that regulate programmed cell death in sympathetic neurons. In this article, we review the key papers published in the
past few years, covering all aspects of apoptosis regulation in sympathetic neurons and focusing, in particular, on how
signalling pathways and transcription factors regulate the cell death programme. We make some comparisons with other models
of neuronal apoptosis and describe possible future directions for the field.
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Facts
 Developing NGF-dependent sympathetic neurons are a
very well characterised model of neuronal apoptosis.
 NGF withdrawal-induced death in vitro requires de novo
gene expression, as does the death of other kinds of
primary neuron, including developing cerebellar granule
neurons (CGNs), motor neurons and cortical neurons.
 NGF deprivation activates the mitochondrial pathway of
apoptosis, and BH3-only proteins and Bax (Bcl-2-associated
x protein) are required for mitochondrial outer membrane
permeabilisation (MOMP) and cytochrome c release.
 The binding of NGF to TrkA activates the PI3K-Akt
(phosphatidylinositol 3-kinase-Akt) and Raf-MEK-ERK
(Raf-MAPK/extracellular signal-regulated kinase kinase-
extracellular signal-regulated kinase) signalling pathways,
which promote the growth and survival of sympathetic
neurons.
 NGF deprivation decreases the activity of the
PI3K-Akt and Raf-MEK-ERK survival pathways, but
increases the activity of theMLK-JNK-c-Jun (mixed lineage
kinase-c-Jun N-terminal kinase-Jun proto-oncogene)
pathway, which is required for the increased expression
of BH3-only proteins and for mitochondrial cytochrome c
release.
Open Questions
 How is the PI3K-Akt pathway inactivated after
NGF withdrawal and how is the JNK pathway
activated?
 How exactly do TrkA and p75NTR (p75 neurotrophin
receptor) regulate NGF withdrawal-induced death?
 How do the new NGF-regulated genes identified by gene
microarray analysis contribute to the control of sympathetic
neuron death and survival?
 How do the core cell death proteins in sympathetic neurons
function in axon degeneration induced by local NGF
deprivation?
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 How similar are the mechanisms of cell death in sympa-
thetic neurons and developing central nervous system
neurons, such as CGNs or cortical neurons?
Apoptosis occurs extensively during the normal development
of the mammalian nervous system and has been observed in
populations of developing neural precursor cells, differen-
tiated postmitotic neurons and glial cells.1–3 These cell deaths
are important for establishing neuronal and glial populations of
the correct size. In the case of the developing peripheral
nervous system (PNS), neuronal apoptosis has been shown
to be important for matching the number of innervating
neurons to the size of the final targets that they innervate.
Sympathetic neurons of the superior cervical ganglion (SCG)
have been extensively studied as a model of naturally
occurring neuronal death in the PNS. During mammalian
development, one-third of these cells normally die by
apoptosis during the first 2 weeks after birth.4 At this time,
sympathetic neurons require nerve growth factor (NGF),
synthesised by their target tissues, for survival.5 NGF is
produced in limiting amounts by the targets innervated by
SCG neurons, and binds to its specific tyrosine kinase
receptor, TrkA, on the surface of the innervating axons.5
The NGF–TrkA complex is then retrogradely transported to
the sympathetic neuron cell bodies and promotes neuronal
growth. Importantly, the binding of NGF to TrkA also inhibits
neuronal apoptosis. Levi-Montalcini and Booker6,7 showed
that injection of a neutralising anti-NGF antiserum into early
postnatal rats or mice greatly reduced the number of SCG
neurons, whereas injection of purified NGF increased their
number.6,7 In agreement with these classic studies, targeted
knockout of the TrkA or Ngf genes in mice also reduces the
number of SCG neurons by increasing the amount of neuronal
death that occurs.5,8,9
Basic Features of Sympathetic Neuron Death In Vitro
Developing sympathetic neurons can be isolated from the
SCGs of early postnatal rats ormice, separated from other cell
types and cultured in vitro for extended periods in medium
containing NGF. When deprived of NGF, sympathetic
neurons die over a period of 48–72 h and this death has the
classic hallmarks of apoptosis10–12 (Figure 1). After NGF
withdrawal, sympathetic neurons become atrophied and their
neurites fragment (Figure 1a). There is also a decrease in
glucose uptake and a fall in the overall rates of protein
synthesis and gene transcription.10,11 The nuclei of NGF-
deprived neurons become pyknotic (Figure 1b) and the
Figure 1 Morphological and biochemical changes that occur in sympathetic neurons undergoing programmed cell death in vivo or following NGF withdrawal in vitro.
(a) Morphology of sympathetic neurons isolated from one-day-old rats and cultured for 6 days in vitro and then in the presence and absence of NGF for 48 h. Bar, 25mm.
(b) Apoptotic chromatin condensation and DNA fragmentation in cultured sympathetic neurons visualised by Hoechst 33342 staining and TUNEL analysis. The neurons were
isolated from one-day-old rats, cultured for 6 days in vitro and then in the presence and absence of NGF for 24 h. Bar, 25 mm. (c) TUNEL analysis of apoptosis in the superior
cervical ganglia of one-day-old wild-type and mkp1 / mice. The mkp1 / knockout mutation significantly increases the number of TUNEL-positive cells per ganglion.14
Scale bar, 100mm. (d) NGF withdrawal activates caspase-3 in sympathetic neurons. Neurons were cultured in the presence or absence of NGF for 48 h. The cleaved form of
caspase-3 and nuclear morphology were visualised by staining the neurons with an anti-active caspase-3 antibody and Hoechst 33342. Bar, 25 mm. (e) Distribution of
cytochrome c in normal and apoptotic sympathetic neurons visualised by immunocytochemistry with an anti-cytochrome c antibody. In the presence of NGF, cytochrome c
immunoreactivity is excluded from the nuclear space and has a punctate pattern. In the absence of NGF, a fainter, diffuse staining pattern that occurs throughout the whole cell
is observed. Bar, 25mm
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chromosomal DNA fragments. This can be detected as a
nucleosomal DNA ladder on a gel12 and visualised at the
single neuron level by terminal deoxynucleotidyl transferase
dUTP nick-end labelling (TUNEL) analysis (Figure 1b). In
vivo, TUNEL-positive cells can be detected in the SCGs of
mice during the period of developmental neuronal death, and
the number of TUNEL-positive cells per SCG is altered by
mutations that change the rate of NGF withdrawal-induced
death in vitro13,14 (Figure 1c). Importantly, the NGF with-
drawal-induced death of sympathetic neurons in vitro is
strongly delayed by inhibitors of transcription or protein
synthesis, suggesting that de novo gene expression is
required for the activation of the cell death programme in
these cells.10,12 This is also true for cultured rat or mouse
CGNs deprived of survival signals,15,16 chick motor neurons
deprived of trophic support17 or cortical neuron apoptosis,18
suggesting that this is often a feature of developmental
neuronal death.
The timecourse of key events during NGF withdrawal-
induced death has been carefully documented10,11
(Figure 2). By B22 h after NGF withdrawal, only 50% of
the neurons can be rescued by the readdition of NGF and
this was defined as the commitment point for NGF
withdrawal-induced death. The transcriptional commitment
point is B16 h after NGF withdrawal and this is the time at
which only 50% of the neurons can be rescued by the
addition of inhibitors of transcription or protein synthesis
(Figure 2).
NGF Withdrawal Activates the Mitochondrial (Intrinsic)
Pathway in Sympathetic Neurons
The NGF withdrawal-induced death of sympathetic neurons
requires caspase activity. Activated caspase-3 can be
detected after NGF withdrawal in vitro (Figure 1d) and in
SCGs in vivo during the period of naturally occurring neuronal
death. Caspase inhibitors, such as BAF (boc-aspartyl-(OMe)-
fluoromethyl-ketone), zVAD-fmk (carbobenzoxy-valyl-alanyl-
aspartyl-[O-methyl]- fluoromethylketone) or the baculovirus
p35 protein protect sympathetic neurons against cell death
after NGF deprivation.19–22 NGF withdrawal activates the
mitochondrial (intrinsic) pathway of caspase activation
(Figure 3). Cytochrome c is released from the mitochondria
of NGF-deprived sympathetic neurons and this can be
visualised by cell fractionation and immunoblotting22 or
by immunocytochemistry using an anti-cytochrome c
antibody23,24 (Figure 1e). Importantly, microinjection of a
neutralising anti-cytochrome c antibody inhibits NGF
withdrawal-induced death, suggesting that the released
mitochondrial cytochrome c is functionally important.24
Deletion of the Apaf-1 (apoptotic protease-activating factor-1),
caspase-9 or caspase-3 genes in mice prevents apoptosis
after NGF deprivation, and allows the sympathetic
neurons to recover and survive long-term following readdition
of NGF.25 The readdition of NGF to NGF-deprived
sympathetic neurons in which cytochrome c has been
released leads to the refilling of the mitochondria with
Figure 2 Key events following NGF withdrawal in sympathetic neurons. Sympathetic neurons undergo death 24–48 h after NGF withdrawal. The N-terminal
phosphorylation of c-Jun, the release of cytochrome c from the mitochondria and the activation of caspase-3 are key biochemical changes seen in NGF-deprived sympathetic
neurons. By B16 h after NGF withdrawal, only 50% of the neurons can be rescued by the addition of inhibitors of transcription or protein synthesis (the transcriptional
commitment point) and byB22 h after NGF withdrawal only 50% of the neurons can be rescued by the readdition of NGF (the commitment point for NGF withdrawal-induced
death). By 48 h, almost all of the neurons have undergone apoptosis and the nuclear and morphological changes typical of apoptosis are apparent. Images represent
snapshots of NGF-deprived sympathetic neurons at the timepoints shown. Scale bars, 20 mm
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cytochrome c.22,26 Sympathetic neurons are one of the few
cell types in which this occurs, making this a useful model for
understanding the mitochondrial death commitment point in
general. Overall, these results are consistent with a model in
which mitochondrial cytochrome c release promotes the
formation of the apoptosome, which leads to the activation
of caspase-9, which then cleaves and activates caspase-3
(Figure 3). Caspase-3 is critical for NGF withdrawal-induced
death because early postnatal sympathetic neurons do not
express the related executioner caspase, caspase-7.25
Another interesting feature of the sympathetic neuron model
is that microinjection of purified, functional cytochrome c into
sympathetic neurons cultured in the presence of NGF does
not induce apoptosis.23,24 Sympathetic neurons only become
competent to die in response to cytochrome c injection when
they have been deprived of NGF for several hours.23
Subsequent experiments demonstrated that after NGF with-
drawal, the endogenous caspase inhibitor, X-linked inhibitor
of apoptosis protein (XIAP), substantially decreases in level
and that this is the molecule that protects sympathetic
neurons maintained in NGF-containing medium against
apoptosis induced by injection of cytochrome c27 (Figure 3).
The role of another initiator caspase –caspase-2 – has also
been studied in sympathetic neurons. Caspase-2 is activated
after NGF withdrawal and this activation requires the adaptor
protein RAIDD (RIP-associated ICH-1/CAD-3 homologous
protein with a death domain).28 Knockout of the caspase-2
gene in mice does not delay NGF withdrawal-induced death
in vitro.29,30 However, caspase-9 levels are increased in the
brain and in sympathetic neurons isolated from capase-2
knockout mice, compared with the same tissues from wild-
type mice, suggesting that compensatory changes in cas-
pase-9 expression have occurred.31 Knockdown of caspase-2
or RAIDD in wild-type neurons using siRNAs does reduce the
rate of NGF withdrawal-induced death in vitro.28,32 Interest-
ingly, recent results suggest that caspase-2 may function
upstream of the mitochondrial pathway in sympathetic
neurons and promote cell death by increasing the phosphor-
ylation of c-Jun and the expression of the BH3-only protein
Bim (Bcl-2-interacting mediator of cell death)32 (Figure 3).
Bcl-2 (B-cell CLL/lymphoma 2) family proteins have a key
role in regulating the release of mitochondrial cytochrome c
after NGFwithdrawal33–35 (Figure 3). Overexpression of Bcl-2
protects sympathetic neurons against NGF withdrawal-
induced death36 and inhibits mitochondrial cytochrome c
release.37 Conversely, sympathetic neurons from bcl-2 /
knockout mice die more rapidly after NGF withdrawal,
indicating that the endogenous Bcl-2 protein promotes
sympathetic neuron survival.38 The multidomain proapoptotic
proteins Bax and Bak (Bcl-2-antagonist/killer) are critical for
MOMP, and in many cell types, both proteins are functionally
important.39 However, in the case of sympathetic neurons,
Figure 3 NGF withdrawal activates the mitochondrial (intrinsic) pathway of apoptosis in sympathetic neurons. After NGF withdrawal, the expression of the BH3-only
proteins Dp5, Bim, Puma and Bmf increases.35,53,54 These promote MOMP by binding to and antagonising the antiapoptotic Bcl-2 and Bcl-xL proteins or by directly activating
Bax. The multidomain proapoptotic Bax protein is activated by NGF withdrawal and essential for MOMP and mitochondrial cytochrome c release. Cytosolic cytochrome c
interacts with Apaf-1 and procaspase-9 to form the apoptosome complex, which then cleaves and activates the effector caspase, caspase-3. Bim, Puma, Bax, cytochrome c,
Apaf-1, caspase-9 and caspase-3 have all been shown to be essential for normal NGF withdrawal-induced death in experiments using sympathetic neurons isolated from
specific knockout mice or, in the case of cytochrome c, a neutralising anti-cytochrome c antibody.23–25,37,41,48,56,57 RAIDD and caspase-2 may function upstream of the
mitochondrial pathway in sympathetic neurons and promote cell death by increasing the expression of the BH3-only protein Bim.32 In the presence of NGF, XIAP inhibits
caspases in sympathetic neurons, but after NGF withdrawal, the level of the XIAP protein significantly decreases,27 allowing the intrinsic pathway to activate caspase-3 and
induce cell death. During the later postnatal development of sympathetic neurons, the level of the MiR-29b microRNA increases (from P13 onwards) and this inhibits
expression of the BH3-only proteins and contributes to the resistance of late postnatal (P28) sympathetic neurons to NGF deprivation-induced death54,118
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only Bax is required for mitochondrial cytochrome c release
andNGFwithdrawal-induced death. Overexpression of Bax in
sympathetic neurons is sufficient to induce cytochrome c
release and apoptosis in the presence of NGF.37,40 Impor-
tantly, sympathetic neurons isolated from bax / knockout
mice are strongly protected against NGF withdrawal-induced
death in vitro and will survive for extended periods in the
absence of NGF, although the neurons still become atro-
phied.41 In addition, the number of sympathetic neurons
isolated from the SCGs of postnatal day 1 (P1) bax / mice
is increased by 2.5-fold compared with wild-type mice.41 On
the other hand, inactivation of the bak gene in mice has no
effect on the rate of NGF withdrawal-induced death.42
Interestingly, sympathetic neurons express the N-Bak tran-
script, which is a neuron-specific splice variant of the Bak
mRNA.43 The variant Bak protein encoded by this transcript
only retains the BH3 domain and lacks the other BH domains.
However, the N-Bak protein is not expressed in sympathetic
neurons and this is due to translational repression mediated
by sequences in the 50- and 30-UTRs of theN-BakmRNA.44,45
How does NGF withdrawal regulate the activity of Bax and
Bcl-2 in sympathetic neurons? Bax translocates to the
mitochondria after NGF withdrawal and both this and
mitochondrial cytochrome c release are inhibited by cyclo-
heximide, suggesting that de novo protein synthesis is
required for Bax translocation and MOMP.24,46 The expres-
sion of four different BH3-only members of the Bcl-2
family – Dp5 (neuronal death protein Dp5), Bim, Puma
(p53 upregulated modulator of apoptosis) and Bmf (Bcl-2
modifying factor) – increases after NGF withdrawal37,47–53
(Figure 3). Furthermore, the BimEL (the largest isoform of Bim),
Puma and Bmf proteins clearly increase in level after NGF
deprivation and this starts before the transcriptional commit-
ment point.37,48,50,51,54 Sympathetic neurons have been
isolated from the SCGs of knockout mice specific for the
different BH3-only protein genes and the effect of each
mutation on NGF withdrawal-induced death has been studied.
Knockout of bad (Bcl-2-associated agonist of cell death) or bid
(BH3 interacting domain death agonist) has no effect on the
rate of cell death after NGF deprivation42 and the inactivation of
dp5 only has a minor effect on NGF withdrawal-induced
death.55,56 The role of the bmf gene has not been studied yet.
However, knockout of either bim or puma very significantly
delays cell death after NGF withdrawal, suggesting that BimEL
and Puma have important roles.37,48,56,57 In both cases, the
protection against cell death is partial and this may be because
Puma can partially compensate for the loss of Bim and vice
versa. This hypothesis could be tested by culturing sympathetic
neurons from bim / puma / double-knockout mice.
This type of experiment has been carried out with mouse
CGNs: knockout of bim or puma or bid only partially protects
CGNs against apoptosis induced by survival signal withdrawal
(extracellular KCl deprivation) but bim / puma / bid /
triple knockout CGNs are highly resistant to apoptosis
induced by KCl deprivation.58 The role of bim and puma has
not yet been studied in developing SCG neurons in vivo, but
knockout of bim has been shown to significantly reduce the
number of TUNEL-positive dorsal root ganglion neurons
during embryonic development, at E14.5 or E15.5.48,59 In
the case of sympathetic neurons in vivo, it would be interesting
to compare the number of TUNEL-positive neurons per SCG
and the total number of SCG neurons in bim  / puma  /
double-knockout mice, bim  / mice, puma  / mice
and wild-type mice, at the time of naturally occurring
neuronal death.
In cultured sympathetic neurons, BimEL has been shown to
be present at the mitochondria after NGF withdrawal48 and
overexpression of BimEL in the presence of NGF is sufficient
to trigger mitochondrial cytochrome c release and apopto-
sis.37 These results suggest amodel in which Dp5, Bim, Puma
and Bmf rapidly increase in level after NGF withdrawal and
promote MOMP in sympathetic neurons, with Bim and Puma
having major roles, by binding to antiapoptotic Bcl-2 family
proteins, such as Bcl-2, and thereby preventing them from
inhibiting Bax-dependent cytochrome c release (Figure 3). In
addition, BimEL and Puma may also directly bind to and
activate Bax, as suggested by work on Bax in other
systems.39,60–62
Changes in Gene Expression After NGF Withdrawal
It has been 25 years since Martin et al.10 reported that RNA
and protein synthesis are necessary for neuronal death
caused by NGF deprivation and proposed that de novo gene
expression is required for cell death to occur. This key study
contributed to the idea of apoptosis as an active form of cell
death and led to the search for proapoptotic genes that are
induced in NGF-deprived sympathetic neurons. Early studies
based on specific hypotheses identified cyclin D1, c-jun and
mkp1 (MAP kinase phosphatase 1), among others, as genes
upregulated after NGF withdrawal.63–65 c-Jun is a member of
the Jun and Fos family of basic/leucine zipper transcription
factors, which together with activating transcription factor 2
(ATF2) constitute the transcription factor activator protein-1
(AP-1). c-Jun/c-Fos heterodimers bind to the AP-1 site
(50-TGACTCA-30) with high affinity, whereas c-Jun/ATF2
heterodimers prefer to bind to ATF sites (50-TGACGTCA-30).
The c-junmRNA and protein increase in level soon after NGF
withdrawal, whereas the other members of the AP-1 family do
not change in level.64,65 Themicroinjection of c-Jun antibodies
or expression of a dominant-negative c-Jun mutant or a
conditional knockout of the c-jun gene in sympathetic neurons
protects the cells against NGF withdrawal-induced death64–66
and suggests that the transcriptional induction of AP-1 target
genes is important for cell death following NGF deprivation.
c-Jun N-terminal phosphorylation also increases after NGF
withdrawal.65,67–69 This phosphorylation increases the tran-
scriptional activity of c-Jun and is mediated by JNKs.70
Several other NGF withdrawal-regulated genes that pro-
mote neuronal apoptosis were discovered either by looking at
the expression of specific genes (bim, p63, puma) or in mRNA
differential display experiments (dp5, egln3 (Egl nine homo-
logue 3)).13,37,47,48,51,71 For each of these genes, the mRNA
and protein increases in level after NGF withdrawal and
experiments with knockout mice have demonstrated that bim,
puma, p63 and egln3 are required for normal NGFwithdrawal-
induced death.13,37,48,51,57,71–73 The BH3-only protein genes
bim and dp5 are direct targets of c-Jun,37,52,74,75 and the Dp5
and Bim proteins, together with Puma and Bmf, promote
MOMP after NGF withdrawal (Figure 3). However, other
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genes induced after NGF deprivation may be important in
other aspects of NGF withdrawal-induced death, for example,
the inhibition of protein synthesis and growth or the regulation
of specific intracellular signalling pathways. Gene microarray
technology has now been used to study the pattern of
expression of all known genes in NGF-deprived sympathetic
neurons.53 Using Affymetrix exon arrays, 415 up- and 813
downregulated genes were identified, including most of the
genes previously known to be regulated by NGF withdrawal.
One of the known induced genes wasmkp1, which encodes a
mitogen-activated protein kinase (MAPK) phosphatase that
can dephosphorylate JNKs. Mkp1 is part of a negative
feedback loop induced by the JNK-c-Jun signalling pathway,
which inhibits JNK activity and thereby modulates the rate of
neuronal death following NGF withdrawal.14
The expression of two members of the p53 family, DNp73
and TAp63, changes in sympathetic neurons following NGF
withdrawal. DNp73, an N-terminally truncated isoform of p73,
decreases in level after NGF deprivation and has been shown
to promote the survival of sympathetic neurons.76 DNp73may
function by acting as an antagonist of p53 family transactivator
proteins or by binding directly to JNKs and inhibiting their
activity.77 Following NGF withdrawal, TAp63, which is a
transcriptional activator closely related to p73, increases in
level.13 Overexpression of TAp63 induces neuronal apoptosis
in the presence of NGF and p63 / sympathetic neurons
are resistant to NGF withdrawal-induced death, suggesting
that p63 has an important role in developmental neuronal
apoptosis.13
The use of an MLK inhibitor, CEP-11004, which inhibits the
activation of the JNK-c-Jun pathway after NGF withdrawal,
has allowed the identification of NGF withdrawal-regulated
genes that may be downstream targets of the JNK path-
way.53,78 However, the induction of some genes, such as
egln3, which encodes a prolyl hydroxylase that destabilises
hypoxia-inducible factor (HIF), is not affected by CEP-
11004.53 Egln3 transcription may be regulated by other
transcription factors that are activated after NGF withdrawal,
but not regulated by the JNK pathway. Under normal oxygen
tensions, the EglN3 protein hydroxylates specific proline
residues in HIF-1a and HIF-2a. The hydroxylated proteins are
then bound by the von Hippel–Lindau protein and its
associated E3 ubiquitin ligase, resulting in their polyubiquiti-
nation and degradation by the proteasome. It has been
proposed that EglN3may promote the death of NGF-deprived
neurons in part by suppressing a HIF-2a-mediated survival
pathway.79
Receptors and Intracellular Signalling Pathways that
Regulate Sympathetic Neuron Survival
NGF was the first growth factor to be discovered80 and
regulates the growth, survival and differentiation of sensory
and sympathetic neurons by binding to two types of cell
surface receptor: the TrkA tyrosine kinase and the p75NTR,
which are often present on the same cell. Binding of NGF to
TrkA leads to receptor dimerisation and tyrosine residue
phosphorylation of the cytoplasmic tail by adjacent Trk
receptors.81 When NGF is bound to TrkA, the receptor
transmits positive signals that enhance sympathetic neuron
growth and survival.82 The binding of NGF to TrkA activates
the small GTPase Ras, which promotes neuronal survival by
activating the PI3K-Akt and Raf-MEK-ERK pathways and also
by inhibiting the JNK pathway.83 The p75NTR receptor can
transmit survival signals with TrkA in response to NGF, and
also induces cell death upon binding BDNF (which does not
bind to TrkA). Experiments with p75NTR / knockout mice
demonstrated that p75 is required for the NGF withdrawal-
induced death of sympathetic neurons and activation of
p75NTR using BDNF increases the N-terminal phosphoryla-
tion of c-Jun and induces apoptosis.84 Subsequent studies
showed that p75NTR can activate the JNK pathway specifi-
cally through JNK3 in sympathetic neurons.85 Recently, it was
suggested that TrkA can behave as a dependence receptor
and induces the death of sympathetic neurons in the absence
of NGF and this TrkA-induced death requires p75NTR.86
However, the biochemical mechanism by which TrkA func-
tions as a dependence receptor has not yet been reported.
When NGF binds to TrkA, the PI3K-Akt pathway is
activated82 (Figure 4) and promotes both the survival and
growth of sympathetic neurons.87 Akt can inhibit apoptosis by
phosphorylating and thereby inhibiting the BH3-only protein
Bad and the transcription factor forkhead box O3a (FOXO3a).
FOXO3a can induce Bim expression when overexpressed
and promotes the death of sympathetic neurons in a Bim-
dependent manner.50 NGF withdrawal causes a rapid
decrease in PI3K and Akt activity, which leads to an increase
Figure 4 Survival pathways activated by the binding of NGF to TrkA. The
binding of NGF to its receptor TrkA can activate the PI3K-Akt signalling pathway,
which can inhibit apoptosis and promote cell survival. The binding of NGF to TrkA
triggers the activation of the small GTP-binding protein Ras. The subsequent
activation of Akt through PI3K can inhibit apoptosis by phosphorylating, and
therefore inactivating, proapoptotic proteins such as the BH3-only protein Bad and
the transcription factor FOXO. The binding of NGF to its receptor TrkA can also
activate the Raf-MEK-ERK signalling pathway. This pathway promotes survival by
inhibiting the expression of Bim, and by activating Rsk, which phosphorylates and
activates the transcription factor CREB, which can activate the transcription of the
bcl-2 gene
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in the amount of FOXO3a in the nucleus, where it induces the
transcription of proapoptotic genes such as bim. The binding
of NGF to TrkA also activates the Raf-MEK-ERK signalling
pathway, which can inhibit apoptosis and promote cell survival
(Figure 4).67,82 This protein kinase cascade has many effects
on neurons, such as an increase in axonal growth in
sympathetic neurons after ERK activation.88 The Raf-MEK-
ERK pathway may suppress apoptosis by phosphorylating
and inactivating the Bim protein89,90 and by activating the
protein kinase Rsk. Rsk phosphorylates and thereby activates
the prosurvival transcription factor CREB91 (Figure 4).
Furthermore, the Raf-MEK-ERK pathway can reduce the
level of bimRNA in sympathetic neurons and inhibition of both
the PI3K and ERK pathways increases the level of the bim
RNA to a similar extent as NGF withdrawal.92 However,
although the ERK pathway clearly regulates the activity of
proteins that promote or inhibit apoptosis in sympathetic
neurons, such as Bim and CREB, it appears to have a more
minor role than the PI3K-Akt pathway in promoting sympa-
thetic neuron survival in the presence of NGF.82,92,93
In sympathetic neurons, NGF withdrawal leads to the
activation of the stress-responsive MLK-JNK-c-Jun protein
kinase cascade64,65,67–69,94,95 (Figure 5). NGFwithdrawal has
been proposed to promote the formation of a complex
comprising the multidomain protein, plenty of SH3 domains
(POSH), which acts as a scaffold that brings together the
small G-protein Rac1, which is an activator of the JNK
pathway,96 and the other elements of the JNK pathway,97 and
thereby stimulates the phosphorylation of c-Jun. Recent
studies showed that Sh3rf2, a homologue of POSH, acts as
an inhibitor of the MLK-JNK pathway.98 Following NGF
withdrawal, Sh3rf2 levels decrease, which stabilises POSH,
activates JNKs and leads to cell death. The JNK-c-Jun
dependent transcriptional programme is required for apopto-
sis induced by NGF deprivation and is initiated by the
phosphorylation of the Thr-X-Tyr motif of JNKs by MAP
kinase kinase 4/7 (MKK4/7).37,64–66,70,99 Evidence for a role of
the MLK-JNK pathway in neuronal death has come from
studies using the MLK inhibitor, CEP-1347, and its derivative,
CEP-11004,78,100 and from experiments using the JNK-
binding domain (JBD) of JNK-interacting protein-1. The JBD
is a direct and specific inhibitor of JNKs and expression of the
JBD inhibits c-Jun phosphorylation and inhibits NGF with-
drawal-induced apoptosis.101,102 JNKs phosphorylate c-Jun
at serines 63 and 73 and threonines 91 and 93, which
increases the ability of c-Jun to activate the transcription of its
target genes,70 which include c-jun itself, bim, dp5 and mkp1
in sympathetic neurons (Figure 5).14,52,53,69
Another protein kinase-dependent proapoptotic pathway
that is activated after NGF withdrawal involves cell-cycle-
related proteins. In NGF-deprived sympathetic neurons,
activation of the cyclin-dependent kinases (Cdk-4 and
Cdk-6) leads to the phosphorylation of retinoblastoma protein
(Rb) family members, which causes the dissociation of
E2F-Rb (E2 promoter binding factor-Rb) family repressor
complexes and consequent derepression of E2F target
genes, including b-myb and c-myb. Small-molecule Cdk
inhibitors or dominant-negative forms of Cdk-4 or Cdk-6
protect NGF-deprived sympathetic neurons from death,
suggesting that Cdk activation may have a role in the
mechanism by which NGF withdrawal triggers neuronal
death.103,104 siRNAs that knock down the level of the b-Myb
(b-myeloblastosis oncogene) and c-Myb transcription factors
protect sympathetic neurons against NGF withdrawal-
induced death.105 Furthermore, there are two Myb binding
sites in the bim promoter and mutation of these binding sites
prevents the induction of a bim promoter – luciferase reporter
construct (bim-LUC) after NGF withdrawal.106
The expression of Bim in sympathetic neurons is tightly
regulated at both the transcriptional and translational level.35
The bim mRNA increases in level after NGF withdrawal, but
this, as well as the increase in Bim protein level, can be
partially reduced by expressing dominant-negative c-Jun or
by using the MLK inhibitor CEP-11004 or by the JunAA knock-
in mutation in mice, which changes serines 63 and 73 in c-Jun
to alanines.37,48,49,51,53 This indicates that c-Jun contributes
to the increased expression of Bim after NGF withdrawal, and
also suggests that other transcription factors must cooperate
with c-Jun to achieve the maximal induction of Bim expres-
sion. Two conserved binding sites for FOXO transcription
factors were identified in the promoter and first intron of bim
and these sites are required for the induction of a bim-LUC
reporter construct after NGF deprivation and FOXO activity is
required for normal NGF withdrawal-induced death.50,107
More recently, the identification of an inverted CCAAT box
(ICB) in the bim promoter revealed that the trimeric transcrip-
tion factor NF-Y (nuclear transcription factor Y) binds to the
Figure 5 Proapoptotic signalling pathways activated in NGF-deprived
sympathetic neurons. When sympathetic neurons are deprived of NGF, the
MLK-JNK-c-Jun pathway is activated. MLKs phosphorylate MAP kinase kinases
such as MKK4/7, which in turn phosphorylate JNKs. JNK activity increases leading
to the phosphorylation of the AP-1 transcription factors c-Jun and ATF2. This
increases the ability of c-Jun to activate the transcription of target genes such as
bim, dp5 and c-jun itself. c-Jun can also bind to AP-1 sites in the promoter of mkp1,
which encodes a MAPK phosphatase that acts as a negative regulator of the JNK
pathway. The MLK inhibitor CEP-11004, which prevents JNK activation, and
dominant-negative c-Jun reduce the induction of c-Jun, Bim and Dp5 and block cell
death
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bim ICB and both the ICB and NF-Y activity are essential for
the induction of the bim-LUC reporter after NGF withdrawal.108
Furthermore, it was shown that NF-Y and FOXO3a interact
with the coactivators CBP and p300 after NGF deprivation and
that CBP/p300 activity is required for the activation of the
bim promoter. CBP/p300may integrate the different signalling
pathways that cooperatively activate the bim promoter after
NGFwithdrawal through the DNA binding transcription factors
c-Jun, FOXO3a and c-Myb.50,74,107,108
Other Signals that Induce Apoptosis in Sympathetic
Neurons
Sympathetic neurons have been an important model for
studying NGF-regulated developmental neuronal apoptosis.
However, sympathetic neurons have also been very useful for
studying how other signals induce neuronal death, including
DNA-damaging agents, glial cell line-derived neurotrophic
factor (GDNF) withdrawal, ER stress and mutant polyQ-
expanded Huntingtin (Htt) protein. In experiments using the
DNA-damaging agent cytosine arabinoside (araC), apoptosis
is induced in sympathetic neurons via a p53-dependent JNK-
independent mechanism. In this context, the inhibition of the
ERK pathway increases the rate of apoptosis induced by araC
in the presence of NGF, suggesting a protective role for the
ERK pathway.109 GDNF is a neurotrophic factor that can
promote the survival ofB34% of SCG neurons isolated from
1- or 2-day-old rats.110 When these cells are deprived of
GDNF, a novel non-mitochondrial caspase-dependent death
pathway is activated in the neurons, which does not involve
cytochrome c release, Bax, caspase-3 or caspase-9.110
Sympathetic neurons have also been used to identify the
pathway of apoptosis triggered by ER stress, which is often
associated with various pathological conditions. ER stress
induces a neuronal apoptotic pathway that upregulates the
BH3-only genes dp5 and puma and commits neurons to die
before cytochrome c release, which requires Bax activation
and JNK signalling. It also highlights the importance of the
apoptosome as the non-redundant caspase activation path-
way to execute neuronal apoptosis in response to ER
stress.111 Finally, the effect of a polyQ-expanded Htt protein,
which causes Huntington’s disease, has been studied in
sympathetic neurons. In the presence of NGF, expression of
an expanded polyQ Htt aggregating protein causes sympa-
thetic neurons to die, but only slowly, because they express
HSP70, which diverts apoptosis into slow necrosis.112
Future Directions
Our current state of knowledge of the mechanisms of
apoptosis in sympathetic neurons will allow researchers in
the field to investigate a number of interesting questions in the
future. Although much has been learned about the role of
Bcl-2 family members in this system, many important
questions remain to be answered. For example, what is the
consequence of knocking out both bim and puma in
sympathetic neurons? And, how is the expression of these
genes regulated by NGF withdrawal? Some work has been
carried out on the transcriptional control of bim, but relatively
little is known about puma in sympathetic neurons. In other
cell types, puma is a direct target of p53113–116 and also a
target of FOXO3a.117 When sympathetic neurons are treated
with araC, p53 is activated and the expression of Puma
increases, and the resulting araC-induced apoptosis depends
on p53 and puma.57 Therefore, puma might be directly
regulated by p53 family members or FOXO transcription
factors after NGF withdrawal. Exon microarray experiments
have demonstrated that many other genes are induced after
NGF withdrawal.53 Like c-jun, mkp1, dp5 and bim, some of
these are likely to be downstream targets of the JNK-c-Jun
pathway or FOXO transcription factors and it will be
interesting to investigate their function in sympathetic neurons
and study how their expression is regulated.
Sympathetic neurons depend on target-derived NGF for
survival during late embryonic and early postnatal develop-
ment,5 but become independent of NGF at later stages of
development.118 This switch can be reproduced in vitro by
culturing P1 sympathetic neurons for 28 days in NGF-
containing medium. These 28 DIV neurons do not die when
deprived of NGF, even though the JNK-c-Jun pathway is
activated in these cells. The molecular basis for this
phenomenon was investigated by Wright et al.,119 who
observed that Apaf-1 expression is greatly reduced in 28
DIV neurons and P28 superior cervical ganglia owing to
alterations in the chromatin structure of the apaf-1 promo-
ter.119 In a more recent study of the changes that occur during
the postnatal development of SCG neurons, Kole et al.54
reported that the microRNAs (miRs) MiR-29a, -29b and -29c
greatly increase in level in SCGs from P13 onwards.54 They
found that increased expression of MiR-29 may contribute to
the resistance of P28 sympathetic neurons to NGF with-
drawal-induced death because MiR-29 binds to the 30-UTR
regions of the mRNAs that encode Dp5, Bim, Puma and Bmf
and inhibits their expression54 (Figure 3). It will be interesting
to study SCG neurons in MiR-29 / knockout mice and to
determine how the expression of MiR-29a, -29b and -29c is
regulated during the postnatal development of SCG
neurons.118
Another important future research direction will be to
understand more precisely how the signalling pathways that
are regulated by NGF withdrawal are activated or inhibited by
the removal of NGF. TrkA has been reported to function as a
dependence receptor and induces cell death in the absence of
NGF.86 It will be interesting to work out how this proapoptotic
function of TrkA is linked to the activation of the MLK-JNK-c-
Jun pathway. At the same time, NGF withdrawal inactivates
the prosurvival PI3K-Akt pathway.82 This inactivation appears
to be mediated in part by the Trib3 protein, which increases in
level after NGF withdrawal.120 Trib3 inhibits Akt activity and
thereby activates FOXO3a, which in turn binds to and
activates the trib3 promoter.120 This constitutes a feedforward
loop and it will be important to identify other molecules that
function in regulatory loops that activate or inhibit the MLK-
JNK-c-Jun and PI3K-Akt pathways in sympathetic neurons.
A recent study investigated the role of components of the
mitochondrial pathway in axon degeneration induced by local
NGF deprivation in vitro.121 In these experiments, the
sympathetic neurons were cultured in microfluidic chambers
so that the cell bodies and distal part of the axons were in
separate compartments. Removal of NGF from the distal
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axons induced axon degeneration, but did not trigger
apoptosis in the cell bodies, which were protected by XIAP.
This axon degeneration required Bax, caspase-9, caspase-3,
caspase-6 but not Apaf-1.121 This suggests that local NGF
deprivation induces an alternative caspase activation path-
way that is independent of the conventional apoptosome and
this will certainly be an interesting area of research in the
future.
Finally, some of the molecular mechanisms that were
discovered using the sympathetic neuron model have also
been studied in other models of developmental neuronal
apoptosis and in cell culture and in vivo models of
neurodegeneration. For example, the JNK-c-Jun pathway
was first reported to promote cell death in sympathetic
neurons and differentiated PC12 cells following NGF with-
drawal.64,65,67 It was then found to have a proapoptotic role in
some animal models of neuronal injury or neurodegeneration
including the kainic acid-induced excitotoxic death of hippo-
campal neurons,122,123 cerebral ischaemia-induced cortical
neuron death,124 the MPTP-induced death of dopaminergic
neurons, which is a model for Parkinson’s disease125 and in
the optic nerve crush-induced death of retinal ganglion
cells.126 It will be interesting to see which other features of
NGF withdrawal-induced death are important for neuronal
apoptosis in other regions of the developing and adult nervous
system. In conclusion, it is likely that the sympathetic neuron
model will continue to be much studied in the future and will
provide further important insights that increase our under-
standing of the mechanisms of neuronal apoptosis during
normal neural development and following injuries to the
nervous system.
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